Venlafaxine ER

DRUG9 trials

Conditions

Anxiety DisordersDepressive Disorder, MajorHealthyMajor Depressive DisorderPanic DisorderRecurrenceSocial Anxiety Disorder

Phase 2

Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

TerminatedNCT00083980

National Center for Complementary and Integrative Health (NCCIH)Anxiety Disorders

Start: 2002-06-30End: 2004-08-31Updated: 2012-10-19

Phase 3

Study Evaluating Venlafaxine ER in Adults With Panic Disorder

CompletedNCT00038896

Wyeth is now a wholly owned subsidiary of PfizerPanic Disorder

Start: 2001-04-30End: 2002-12-31Updated: 2009-08-14

Study Evaluating Venlafaxine ER in Patients With Panic Disorder

CompletedNCT00044772

Wyeth is now a wholly owned subsidiary of PfizerPanic Disorder

Start: 2001-11-30End: 2003-04-30Updated: 2009-08-14

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

CompletedNCT00087737

Wyeth is now a wholly owned subsidiary of PfizerMajor Depressive Disorder

End: 2005-05-31Updated: 2009-08-19

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

CompletedNCT00238719

Wyeth is now a wholly owned subsidiary of PfizerSocial Anxiety Disorder

Start: 1999-12-31End: 2003-06-30Target: 293Updated: 2006-05-19

Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects

CompletedNCT00329186

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-05-31End: 2007-06-30Updated: 2013-02-08

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

CompletedNCT01485887

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Major Depressive Disorder

Start: 2012-01-31End: 2014-01-31Updated: 2021-01-28

Phase 4

Study Evaluating Venlafaxine ER in Recurrent Depression

CompletedNCT00046020

Wyeth is now a wholly owned subsidiary of PfizerDepressive Disorder, Major, Recurrence

Start: 2000-08-31End: 2005-10-31Updated: 2009-08-14

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

CompletedNCT00401726

Wyeth is now a wholly owned subsidiary of PfizerDepressive Disorder, Major

Start: 2006-06-30End: 2007-10-31Updated: 2012-04-23

Related Papers

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine

The Journal of Clinical Psychiatry2013-11-2049 citations

A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.

2009-04-0719 citations

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

2007-08-0167 citations

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.

2007-07-0139 citations